Abstract
The Asian Pacific Association for the Study of the Liver (APASL) set up a Working Party on Portal Hypertension in 2002, with a mandate to develop consensus guidelines on various clinical aspects of portal hypertension relevant to disease patterns and clinical practice in the Asia-Pacific region. Variceal bleeding is a consequence of portal hypertension, which, in turn, is the major complication of liver cirrhosis. Primary prophylaxis to prevent the first bleed from varices is one of the most important strategies for reducing the mortality in cirrhotic patients. Experts predominantly from the Asia-Pacific region were requested to identify the different aspects of primary prophylaxis and develop the consensus guidelines. The APASL Working Party on Portal Hypertension evaluated the various therapies that have been used for the prevention of first variceal bleeding. A 2-day meeting was held on January 12 and 13, 2007, at New Delhi, India, to discuss and finalize the consensus statements. Only those statements that were unanimously approved by the experts were accepted. These statements were circulated to all the experts and were subsequently presented at the annual conference of the APASL at Kyoto, Japan, in March 2007.
Similar content being viewed by others
Abbreviations
- APASL:
-
Asian Pacific Association for the Study of the Liver
- UGIE:
-
Upper gastro-intestinal endoscopy
- HVPG:
-
Hepatic venous pressure gradient
- IAP:
-
Intra-abdominal pressure
- VBL:
-
Variceal band ligation
- ISMN:
-
Isosorbide-5-mononitrate
- EIS:
-
Endoscopic injection sclerotherapy
- B-RTO:
-
Balloon-occluded retrograde transvenous obliteration
- BO-EIS:
-
Balloon-occluded endoscopic injection sclerotherapy
References
de Franchis R. Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167–176
Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Practice Guidelines Committee of the American Association for the Study of Liver Diseases. Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46(3):922–938. doi:10.1002/hep.21907
Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 1997;92:1081–1091
Centre for evidence-based medicine. Levels of evidence. 2001. http://www.cebm.net/index.aspx?o=1047. Accessed 23 Aug 2008
de Franchis R, Pascal JP, Burroughs AK, Henderson JM, Fleig W, Groszmann RJ, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A consensus development workshop. J Hepatol 1992;15:256–261. doi:10.1016/0168-8278(92)90044-P
Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998;28:868–880. doi:10.1002/hep.510280339
D’Amico G, Garcia-Tsao G, Cales P, Escorsell A, Nevens F, Cestari R, et al. Diagnosis of portal hypertension: how and when. In de Franchis R, editor. Portal Hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford, UK: Blackwell Science; 2001. 36–64
The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988;319:983–989
El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000;95:3566–3573. doi:10.1111/j.1572-0241.2000.03376.x
D’Amico G, de Franchis R. Upper digestive bleeding in cirrhosis. Posttherapeutic outcome and prognostic indicators. Hepatology 2003;38:599–612. doi:10.1053/jhep.2003.50385
Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004;40:652–659. doi:10.1002/hep.20339
Moitinho E, Escorsell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodes J, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999;117:626–631. doi:10.1016/S0016-5085(99)70455-5
Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Portal Hypertension Collaborative Group. Betablockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254–2261. doi:10.1056/NEJMoa044456
D’Amico G, Morabito A. Noninvasive markers of esophageal varices: another round, not the last. Hepatology 2004;39:30–34. doi:10.1002/hep.20018
Eisen GM, Eliakim R, Zaman A, Schwartz J, Faigel D, Rondonotti E, et al. The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three-center pilot study. Endoscopy 2006;38:31–35. doi:10.1055/s-2005-921189
Lapalus MG, Dumortier J, Fumex F, Roman S, Lot M, Prost B, et al. Esophageal capsule endoscopy versus esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance. Endoscopy 2006;38:36–41. doi:10.1055/s-2006-924975
Reliability of endoscopy in the assessment of variceal features: the Italian Liver Cirrhosis Project. J Hepatol 1987;4:93–98. doi:10.1016/S0168-8278(87)80015-6
Sarin S, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999;340:988–993. doi:10.1056/NEJM199904013401302
Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003;38:266–272. doi:10.1016/S0168-8278(02)00420-8
Conn HO, Grace ND, Bosch J, Groszmann J, Rodes J, Wright SC, et al. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: a multicenter, randomized clinical trial. Hepatology 1991;13:902–912
The PROVA Study Group. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients. A randomized multicenter trial. Hepatology 1991;14:1016–1024
Angelico M, Carli L, Piat C, Gentile S, Capocaccia L. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis. Gastroenterology 1997;113:1632–1639. doi:10.1053/gast.1997.v113.pm9352866
Garcia-Pagan JC, Villanueva C, Vila MC, Albillos A, Genesca J, Ruiz del Arbol L, et al. Mononitrato Varices Esofagicas: isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers. Gastroenterology 2001;121:908–914. doi:10.1053/gast.2001.27993
Merkel C, Marin R, Sacerdoti D, Donada C, Cavallarin G, Torboli P, et al. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000;31:324–329. doi:10.1002/hep.510310210
Cales P, Oberti F, Payen JL, Naveau S, Guyader D, Blanc P, et al. Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-speaking Club for the study of portal hypertension. Eur J Gastroenterol Hepatol 1999;11:741–745. doi:10.1097/00042737-199907000-00011
Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 2004;127:476–484. doi:10.1053/j.gastro.2004.05.004
Staritz M, Poralla T, Meyer zum Büschenfelde KH. Intravascular oesophageal variceal pressure (IOVP) assessed by endoscopic fine needle puncture under basal conditions, Valsalva’s manoeuvre and after glyceryltrinitrate application. Gut 1985;26(5):525–530. doi:10.1136/gut.26.5.525
Kravetz D, Romero G, Argonz J, Guevara M, Suarez A, Abecasis R, et al. Total volume paracentesis decreases variceal pressure, size, and variceal wall tension in cirrhotic patients. Hepatology 1997;25(1):59–62. doi:10.1002/hep.510250111
Luca A, Feu F, García-Pagán JC, Jiménez W, Arroyo V, Bosch J, et al. Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites. Hepatology 1994;20(1 Pt 1):30–33
Escorsell A, Ginès A, Llach J, García-Pagán JC, Bordas JM, Bosch J, et al. Increasing intra-abdominal pressure increases pressure, volume, and wall tension in esophageal varices. Hepatology 2002;36(4 Pt 1):936–940
Luca A, Cirera I, García-Pagán JC, Feu F, Pizcueta P, Bosch J, et al. Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis. Gastroenterology 1993;104(1):222–227
García-Pagàn JC, Santos C, Barberá JA, Luca A, Roca J, Rodriguez-Roisin R, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology 1996;111(5):1300–1306. doi:10.1053/gast.1996.v111.pm8898644
Bandi JC, García-Pagán JC, Escorsell A, François E, Moitinho E, Rodés J, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology 1998;28(3):677–682. doi:10.1002/hep.510280312
Feu F, Bordas JM, Luca A, García-Pagán JC, Escorsell A, Bosch J, et al. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Hepatology 1993;18(5):1082–1089
Luca A, García-Pagán JC, Bosch J, Feu F, Caballería J, Groszmann RJ, et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997;112(4):1284–1289. doi:10.1016/S0016-5085(97)70142-2
Ready JB, Hossack KF, Rector WG Jr. The effects of ethanol administration on portal pressure and gastroesophageal collateral blood flow in patients with alcoholic cirrhosis. Hepatology 1990;11(4):674–677. doi:10.1002/hep.1840110422
Albillos A, Bañares R, González M, Catalina MV, Pastor O, Gonzalez R, et al. The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosis. Gut 2007;56(2):259–264. doi:10.1136/gut.2006.095240
Albillos A, Rossi I, Iborra J, Lledó JL, Calleja JL, Barrios C, et al. Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension. J Hepatol 1994;21(1):88–94. doi:10.1016/S0168-8278(94)80142-8
Ludwig D, Schädel S, Brüning A, Schiefer B, Stange EF. 48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study. Dig Dis Sci 2000;45(5):1019–1027. doi:10.1023/A:1005553914878
Buonamico P, Sabbá C, Garcia-Tsao G, Berardi E, Antonica G, Ferraioli G, et al. Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: a double-blind randomized echo-Doppler study. Hepatology 1995;21(1):134–139
de Lédinghen V, Mannant PR, Foucher J, Perault MC, Barrioz T, Ingrand P, et al. Non-steroidal anti-inflammatory drugs and variceal bleeding: a case-control study. J Hepatol 1996;24(5):570–573. doi:10.1016/S0168-8278(96)80142-5
de Lédinghen V, Heresbach D, Fourdan O, Bernard P, Liebaert-Bories MP, Nousbaum JB, et al. Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut 1999;44(2):270–273
Colle I, De Vriese AS, Van Vlierberghe H, Lameire NH, DeVos M. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients. Liver Int 2004;24(1):63–68. doi:10.1111/j.1478-3231.2004.00892.x
Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, et al. Betaadrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials, Franco-Italian Multicenter Study Group. N Engl J Med 1991;324:1532–1538
Pagliaro L, D’Amico G, Sorensen TI, Lebrec D, Burroughs AK, Morabito A, et al. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med 1992;117:59–70
D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475–505
Merkel C, Bolognesi M, Sacerdoti D, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000;32:930–934. doi:10.1053/jhep.2000.19322
Bosch J. A la carte or menu fixed: improving pharmacologic therapy of portal hypertension. Hepatology 2002;36:1330–1332
Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056–1059. doi:10.1016/S0140-6736(95)91740-3
Villanueva C, Balanzo J, Novella MT, Soriano G, Sainz S, Torras X, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 1996;334:1624–1629. doi:10.1056/NEJM199606203342502
Bureau C, Peron JM, Alric L, Morales J, Sanchez J, Barange K, et al. “A la carte” treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002;36:1361–1366
Aracil C, Lopez-Balaguer JM, Monfort D, Piqueras M, Gonzalez B, Minana J, et al. Hemodynamic response to beta-blockers and prediction of clinical efficacy in the primary prophylaxis of variceal bleeding in patients with cirrhosis. Hepatology 2003;38:296A. abstract doi:10.1016/S0270-9139(03)80334-8
Sarin SK, Guptan RC, Jain AK, Sundaram KR. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol Hepatol 1996;8:337–342. doi:10.1097/00042737-199604000-00010
Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc 2004;59:333–338. doi:10.1016/S0016-5107(03)02819-0
Schepke M, Kleber G, Nurnberg D, Willert J, Koch L, Veltzke-Schlieker W, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2004;40:65–72. doi:10.1002/hep.20284
Lay CS, Tsai YT, Lee FY, Lai YL, Yu CJ, Chen CB, et al. Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis. J Gastroenterol Hepatol 2006;21:413–419. doi:10.1111/j.1440-1746.2005.04071.x
Jutabha R, Jensen DM, Martin P, Savides T, Han SH, Gornbein J. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology 2005;128:870–881. doi:10.1053/j.gastro.2005.01.047
Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Hepatology 2001;33:802–807. doi:10.1053/jhep.2001.23054
Teran JC, Imperiale TF, Mullen KD, Tavill AS, McCullough AJ. Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis. Gastroenterology 1997;112:473–482. doi:10.1053/gast.1997.v112.pm9024301
Shaheen NJ, Stuart E, Scmidt SM, Mitchell K, Fried M, et al. Pantoprazole reduces the size of post banding ulcers after variceal band ligation: a randomized controlled trial. Hepatology 2005;41:588–594. doi:10.1002/hep.20593
Yoshida H, Mamada Y, Taniai N, Yamamoto K, Kawano Y, Mizuguchi Y, et al. A randomized control trial of bi-monthly versus bi-weekly endoscopic variceal ligation of oesophageal varices. Am J Gastroenterol 2005;100(9):2005–2009. doi:10.1111/j.1572-0241.2005.41864.x
De Franchis R. Endoscopy critics vs endoscopy enthusiasts for primary prophylaxis of variceal bleeding. Hepatology 2006;43:24–26. doi:10.1002/hep.21026
Chen CY, Sheu MZ, Su SY. Prophylactic endoscopic variceal ligation (EVL) with multiple band ligator for esophageal varices. Gastroenterology 1998;114(Suppl):A1224. abstract
De BK, Ghoshal UK, Das T, Santra A, Biswas PK. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial. J Gastroenterol Hepatol 1999;14:220–224. doi:10.1046/j.1440-1746.1999.01800.x
Lui HF, Stanley AJ, Forrest EH, Jalan R, Hislop WS, Mills PR, et al. Primary prophylaxis of variceal haemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002;123:735–744. doi:10.1053/gast.2002.35385
Thuluvath PJ, Maheshwari A, Jagannath S, Arepally A. A randomized controlled trial of β-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Dig Dis Sci 2005;50:407–410. doi:10.1007/s10620-005-1619-8
Psilopoulos D, Galanis P, Goulas S, Papanikolaou IS, Elefsiniotis I, Liatsos C, et al. Endoscopic variceal ligation vs. propranolol for prevention of first variceal bleeding: a randomized controlled trial. Eur J Gastroenterol Hepatol 2005;17(10):1111–1117. doi:10.1097/00042737-200510000-00016
Khuroo MS, Khuroo NS, Farahat KLC, Khuroo YS, Sofi AA, Dahab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005;21:347–361. doi:10.1111/j.1365-2036.2005.02346.x
Sarin SK, Wadhawan M, Agarwal SR, Tyagi P, Sharma BC. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol 2005;100:797–804. doi:10.1111/j.1572-0241.2005.40468.x
Angelico M, Carli L, Piat C, Gentile S, Rinaldi V, Bologna E, et al. Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology 1993;104:1460–1465
Groszmann RJ. Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly. Gastroenterology 1998;113:1794–1797. doi:10.1053/gast.1997.v113.agast971131794
Borroni G, Salerno F, Cazzaniga M, Bissoli F, Lorenzano E, Maggi A, et al. Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites. J Hepatol 2002;37:315–321. doi:10.1016/S0168-8278(02)00174-5
Merkel C, Marin R, Enzo E, Donada C, Cavallarin G, Torboli P, et al. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Lancet 1996;348:1677–1681. doi:10.1016/S0140-6736(96)05406-2
Garcia-Pagan JC, Morillas R, Banares R, Albillos A, Villanueva C, Vila C, et al. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatology 2003;37:1260–1266. doi:10.1053/jhep.2003.50211
D’Amico G, Pasta L, Politi F, Vizzini G, Traina M, Caltagirone M, et al. Isosorbide mononitrate with nadolol compared to nadolol alone for prevention of the first bleeding in cirrhosis. A double-blind placebo-controlled randomized trial. Gastroenterol Int 2002;15:40–50
Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16:1343–1349. doi:10.1002/hep.1840160607
Sarin SK, Primignani M, Agarwal SR. Gastric varices. In: De Franchis R, editor. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science; 2001. p. 76–96
Hosking SW, Johnson AG. Gastric varices: a proposed classification leading to management. Br J Surg 1988;75:195–196. doi:10.1002/bjs.1800750303
Kim T, Shijo H, Kokawa H, Tokumitsu H, Kubara K, Ota K, et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997;25:307–312. doi:10.1002/hep.510250209
Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Endoscopic classification of gastric varices. Gastrointest Endosc 1990;36:276–280
Arakawa M, Masuzaki T, Okuda K. Pathology of fundic varices of the stomach and rupture. J Gastroenterol Hepatol 2002;17:1064–1069. doi:10.1046/j.1440-1746.2002.02855.x
D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332–354
Ramond MJ, Valla D, Mosnier JF, Degott C, Bernuau J, Rueff B, et al. Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology 1989;10:488–493. doi:10.1002/hep.1840100415
Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 1995;27:349–354
Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 2002;97:1010–1015. doi:10.1111/j.1572-0241.2002.05622.x
Rengstorff DS, Binmoeller KF. A pilot study of 2-octyl-cyanoacrylate injection for treatment of gastric fundal varices in humans. Gastrointest Endosc 2004;59:553–558. doi:10.1016/S0016-5107(03)02865-7
Roesch W, Rexroth G. Pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices. Endoscopy 1998;30:S89–S90
See A, Florent C, Lamy P, Levy VG, Bouvry M. Cerebrovascular accidents after endoscopic obturation of oesophageal varices with isobutyl-2-cyanoacrylate in 2 patients. Gastroenterol Clin Biol 1986;10:604–607
Kanagawa H, Mima H, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996;11:51–58. doi:10.1111/j.1440-1746.1996.tb00010.x
Hamamoto N, Matsumoto A, Nomura T, Kayazawa M, Hirata I, Morikawa H, et al. Treatment of gastric fundal varices by balloon endoscopic sclerotherapy. Gastrointest Endosc 1999;49:115–118. doi:10.1016/S0016-5107(99)70459-1
Shiba M, Higuchi K, Nakamura K, Itani A, Kuga T, Okazaki H, et al. Efficacy and safety of balloon-occluded endoscopic injection for sclerotherapy as a prophylactic treatment for high-risk gastric varices: a prospective, randomized, comparative clinical trial. Gastrointest Endosc 2002;56:522–528. doi:10.1016/S0016-5107(02)70437-9
Matsumoto A, Hamamoto N, Kayazawa M. Balloon endoscopic sclerotherapy, a novel treatment for high-risk gastric fundal varices: a pilot study. Gastroenterology 1999;117:515–516. doi:10.1053/gast.1999.0029900515
Fukuda T, Hirota S, Sugimura K. Long-term results of balloon occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001;12:327–336. doi:10.1016/S1051-0443(07)61912-5
Cho SK, Shin SW, Lee IH, Do YS, Choo SW, Park KB, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol 2007;189(6):W365–W372. doi:10.2214/AJR.07.2266
Arai H, Abe T, Takagi H, Mori M. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol 2006;12(24):3866–3873
Mittal SK, Kalra KK, Aggarwal V. Diagnostic upper GI endoscopy for hematemesis in children: experience from a pediatric gastroenterology centre in north India. Indian J Pediatr 1994;61:651–654. doi:10.1007/BF02751973
Yachha SK, Khanduri A, Sharma BC, Kumar M. Gastrointestinal bleeding in children. J Gastroenterol Hepatol 1996;11:903–907
Cox K, Ament ME. Upper gastrointestinal bleeding in children and adolescents. Pediatrics 1979;63:408–413
Dilawari JB, Chawla YK. Extrahepatic portal venous obstruction. Gut 1988;29:554–555. doi:10.1136/gut.29.4.554
Bernard O, Alvarez F, Brunelle F, Hadchouel P, Alagille D. Portal hypertension in children. Clin Gastroenterol 1985;14:33–55
Howard ER, Stamatakis JD, Mowat AP. Management of esophageal varices in children by injection sclerotherapy. J Pediatr Surg 1984;19:2–5
Howard ER, Stringer MD, Mowat AP. Assessment of injection sclerotherapy in the management of 152 children with esophageal varices. Br J Surg 1988;75:404–408
Goncalves MEP, Cardoso SR, Maksoud JG. Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial. J Pediatr Surg 2000;35:401–405
Arora NK, Lodha R, Gulati S, et al. Portal hypertension in north Indian children. Indian J Pediatr 1998;65:585–591
Celinska-Cedro D, Teisseyre M, Woynarowski M, et al. Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study. J Pediatr Surg 2003;38:1008–1011
Shashidhar H, Langhans N, Grand RJ. Propanolol in prevention of portal hypertensive hemorrhage in children: a pilot study. J Pediatr Gastroenterol Nutr 1999;29:12–17
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Sarin, S.K., Kumar, A., Angus, P.W. et al. Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int 2, 429–439 (2008). https://doi.org/10.1007/s12072-008-9096-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-008-9096-8